Medicines Co. (MDCO) Misses Q4 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results
February 28, 2017 7:00 AM ESTPARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today announced its financial results for the fourth-quarter and full-year ended December 31, 2016.
Driven by strong execution against our strategic priorities, 2016 was a transformative year for the Company, said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company. We announced positive top-line results from... More
